AIM: To elucidate the possible difference in two promoter polymorphisms of the transforming growth factor-beta1 (TGF-beta1) gene (-800G > A, -509C > T) between ulcerative colitis (UC) patients and normal subjects. METHODS: A total of 155 patients with established ulcerative colitis and 139 normal subjects were selected as controls. Two single nucleotide polymorphisms within the promoter region of TGF-beta1 gene (-509C > T and -800G > A) were genotyped using PCR-RFLP. RESULTS: There was a statistically significant difference in genotype and allele frequency distributions between UC patients and controls for the -800G > A polymorphism of the TGF-beta1 gene (P < 0.05). The frequency of the TGF-beta1 gene polymorphism at position -800 showed that the AA genotype and the allele A frequencies significantly differed between the patients and healthy controls (P < 0.05). At position -509, there was no statically significant difference in genotype and allele frequency between the patients and control subjects. CONCLUSION: The results of our study indicate that there is a significant difference in both allele and genotype frequency at position -800G > A of TGF-beta1 gene promoter between Iranian patients with UC and normal subjects.
AIM: To elucidate the possible difference in two promoter polymorphisms of the transforming growth factor-beta1 (TGF-beta1) gene (-800G > A, -509C > T) between ulcerative colitis (UC) patients and normal subjects. METHODS: A total of 155 patients with established ulcerative colitis and 139 normal subjects were selected as controls. Two single nucleotide polymorphisms within the promoter region of TGF-beta1 gene (-509C > T and -800G > A) were genotyped using PCR-RFLP. RESULTS: There was a statistically significant difference in genotype and allele frequency distributions between UC patients and controls for the -800G > A polymorphism of the TGF-beta1 gene (P < 0.05). The frequency of the TGF-beta1 gene polymorphism at position -800 showed that the AA genotype and the allele A frequencies significantly differed between the patients and healthy controls (P < 0.05). At position -509, there was no statically significant difference in genotype and allele frequency between the patients and control subjects. CONCLUSION: The results of our study indicate that there is a significant difference in both allele and genotype frequency at position -800G > A of TGF-beta1 gene promoter between Iranian patients with UC and normal subjects.
Authors: Y Kang; M A Prentice; J M Mariano; S Davarya; R I Linnoila; T W Moody; L M Wakefield; S B Jakowlew Journal: Exp Lung Res Date: 2000-12 Impact factor: 2.459
Authors: K-B Hahm; K M Lee; Y B Kim; W S Hong; W H Lee; S U Han; M W Kim; B O Ahn; T Y Oh; M H Lee; J Green; S J Kim Journal: Aliment Pharmacol Ther Date: 2002-04 Impact factor: 8.171
Authors: Carmen G Tag; Senait Mengsteab; Claus Hellerbrand; Frank Lammert; Axel M Gressner; Ralf Weiskirchen Journal: Cytokine Date: 2003-12-07 Impact factor: 3.861
Authors: Oh Sang Kwon; Suk Ho Song; Ki Tak Ju; Moon Gi Chung; Dong Kyun Park; Sun Suk Kim; Yeon Suk Kim; Yang Suh Koo; Yu Kyung Kim; Duck Joo Choi; Ju Hyun Kim; You Jin Hwang; Kwan Soo Byun; Chang Hong Lee Journal: Korean J Gastroenterol Date: 2003-09
Authors: Chris P Verschoor; Sameer D Pant; Qiumei You; Flavio S Schenkel; David F Kelton; Niel A Karrow Journal: BMC Genet Date: 2010-04-15 Impact factor: 2.797